Skip to content

Clinical study on improving postoperative symptoms of cervical spondylotic myelopathy by Qishe pill

Clinical study on improving postoperative symptoms of cervical spondylotic myelopathy by Qishe pill

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900028173
Enrollment
Unknown
Registered
2019-12-14
Start date
2019-12-01
Completion date
Unknown
Last updated
2019-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical spondylotic myelopathy

Interventions

Sponsors

Longhua Hospital Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria; 2. The patients were aged between 18 and 80 years. 3. Cervical spondylotic myelopathy patients receiving surgical treatment (including anterior and posterior); 4. Signed Informed consent.

Exclusion criteria

Exclusion criteria: 1. Women who are nursing or preparing for pregnancy; 2. Patients with liver, kidney, hematopoietic system, endocrine system and other serious primary diseases and mental diseases; 3. Patients with other spinal diseases, tumors, cerebral infarction, etc. that affect limb sensation and function; 4. A suspected history of alcohol or drug abuse, or, in judgment, a reduced likelihood of inclusion or admission; 5. Subjects who are participating in other drug clinical studies.

Design outcomes

Primary

MeasureTime frame
VAS;JOA;NDI;

Countries

China

Contacts

Public ContactWen Mo

Longhua Hospital Shanghai University of Traditional Chinese Medicine

mw2218@126.com+86 13801968271

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 17, 2026